New Delhi: Leading pharmaceutical company Cipla has sought permission to launch Favipiravir, an anti-viral drug, in India to fight against…
New York: Remdesivir, the anti-viral drug that has shown promise in the fight against COVID-19, has been backed by more…
Another anti-viral drug for the treatment of COVID-19 has been launched, this time by pharma major Cipla. To be sold…